Literature DB >> 25769015

Cystargolides, 20S Proteasome Inhibitors Isolated from Kitasatospora cystarginea.

Krista A Gill1, Fabrice Berrué1,2, Jennifer C Arens3, Gavin Carr2, Russell G Kerr1,2,3.   

Abstract

Two novel β-lactone-containing natural products, cystargolides A (1) and B (2), were isolated from the actinomycete Kitasatospora cystarginea. The production of these two natural products was highlighted using a methodology associating liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analysis and the statistical analysis tool principal component analysis (PCA). Their structures were elucidated by interpretation of NMR experiments and tandem mass spectrometry. The absolute configurations of the amino acid residues were determined using Marfey's method, and the relative configurations of the β-lactone substituents were determined on the basis of the vicinal (3)J(HH) coupling value. Due to the presence of the β-lactone, 1 and 2 were evaluated for their ability to inhibit the human 20S proteasome. 1 and 2 both inhibited the 20S proteasome in vitro with IC50 values of 0.35 and 0.93 μM, respectively.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769015     DOI: 10.1021/np501060k

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

1.  Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B.

Authors:  Rodolfo Tello-Aburto; Liam P Hallada; Doleshwar Niroula; Snezna Rogelj
Journal:  Org Biomol Chem       Date:  2015-09-24       Impact factor: 3.876

2.  Rh-Catalyzed Conjugate Addition of Aryl and Alkenyl Boronic Acids to α-Methylene-β-lactones: Stereoselective Synthesis of trans-3,4-Disubstituted β-Lactones.

Authors:  Christian A Malapit; Irungu K Luvaga; Donald R Caldwell; Nicholas K Schipper; Amy R Howell
Journal:  Org Lett       Date:  2017-08-15       Impact factor: 6.005

3.  Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.

Authors:  Doleshwar Niroula; Liam P Hallada; Camille Le Chapelain; Susantha K Ganegamage; Devon Dotson; Snezna Rogelj; Michael Groll; Rodolfo Tello-Aburto
Journal:  Eur J Med Chem       Date:  2018-08-20       Impact factor: 6.514

4.  Global analysis of biosynthetic gene clusters reveals conserved and unique natural products in entomopathogenic nematode-symbiotic bacteria.

Authors:  Yi-Ming Shi; Merle Hirschmann; Yan-Ni Shi; Shabbir Ahmed; Desalegne Abebew; Nicholas J Tobias; Peter Grün; Jan J Crames; Laura Pöschel; Wolfgang Kuttenlochner; Christian Richter; Jennifer Herrmann; Rolf Müller; Aunchalee Thanwisai; Sacha J Pidot; Timothy P Stinear; Michael Groll; Yonggyun Kim; Helge B Bode
Journal:  Nat Chem       Date:  2022-04-25       Impact factor: 24.274

5.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

6.  Metabolomic study of marine Streptomyces sp.: Secondary metabolites and the production of potential anticancer compounds.

Authors:  Marcelo M P Tangerina; Luciana Costa Furtado; Vida M B Leite; Anelize Bauermeister; Karen Velasco-Alzate; Paula C Jimenez; Leandro M Garrido; Gabriel Padilla; Norberto P Lopes; Leticia V Costa-Lotufo; Marcelo J Pena Ferreira
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

7.  Cystargolide-based amide and ester Pz analogues as proteasome inhibitors and anti-cancer agents.

Authors:  Carlos R Viera; Bradley T Stevens; Talysa Viera; Cameron Zielinski; Lee A Uranga; Snezna Rogelj; Praveen L Patidar; Rodolfo Tello-Aburto
Journal:  R Soc Open Sci       Date:  2022-09-28       Impact factor: 3.653

8.  Metabolomics Tools Assisting Classic Screening Methods in Discovering New Antibiotics from Mangrove Actinomycetia in Leizhou Peninsula.

Authors:  Qin-Pei Lu; Yong-Mei Huang; Shao-Wei Liu; Gang Wu; Qin Yang; Li-Fang Liu; Hai-Tao Zhang; Yi Qi; Ting Wang; Zhong-Ke Jiang; Jun-Jie Li; Hao Cai; Xiu-Jun Liu; Hui Luo; Cheng-Hang Sun
Journal:  Mar Drugs       Date:  2021-12-01       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.